Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121839) titled 'A prospective, multicenter clinical study on myocarditis induced by immune checkpoint inhibitor therapy in tumor patients' on April 3.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Eastern Theater General Hospital of the Chinese People's Liberation Army
Condition:
Solid tumor
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-03
Target Sample Size: The group for observing solid tumors:3000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=315303
Published by HT Digital Content Services with pe...